证券代码：300012 证券简称：华测检测 公告编号：2023-060 华测检测认证集团股份有限公司 关于回购股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于 2023 年 5 月 15 日召开第六届董事会第四次会议审议通过了《关于回购公司股份方案的议案》， 公司计划使用自有资金以集中竞价方式回购公司股份，回购的公司股份用于员工 持股计划或股权激励。本次拟回购股份数量为 300 万股-500 万股，回购股份价格 不超过人民币 25 元/股，按照回购数量上限 500 万股和回购价格上限 25 元/股的 条件下测算，预计回购金额不超过 12,500 万元，具体回购股份的数量以回购结束 时实际回购的股份数量为准。本次回购实施期限为自公司董事会审议通过本次回 购股份方案之日起不超过 12 个月。具体内容详见公司 2023 年 5 月 16 日、2023 年 5 月 18 日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于回购公司 股份方案的公告》（公告编号：2023-033 ...

证券代码：300012 证券简称：华测检测 公告编号：2023-059 华测检测认证集团股份有限公司 关于首次回购公司股份的公告 《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》第十七条、第 十八条、第十九条的相关规定。具体如下： 1、公司未在下列期间内回购公司股份： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于 2023 年 5 月 15 日召开第六届董事会第四次会议审议通过了《关于回购公司股份方案的议案》， 公司计划使用自有资金以集中竞价方式回购公司股份，回购的公司股份用于员工 持股计划或股权激励。本次拟回购股份数量为 300 万股-500 万股，回购股份价格 不超过人民币 25 元/股，按照回购数量上限 500 万股和回购价格上限 25 元/股的 条件下测算，预计回购金额不超过 12,500 万元，具体回购股份的数量以回购结束 时实际回购的股份数量为准。本次回购实施期限为自公司董事会审议通过本次回 购股份方案之日起不超过 12 个月。具体内容详见公司 2023 年 5 月 16 日、202 ...

Training and Development - In the first half of 2023, the company conducted 6 online live courses and 12 offline training sessions for key technical positions, covering 1,430 participants and totaling 10,572 hours of training[4] - The company launched 18 online recorded courses, reaching 16,793 participants with a total of 92,688 hours of training to enhance QHSE comprehensive quality[4] - The company conducted 6 online and 12 offline training sessions for QHSE core positions, covering 1,430 participants and totaling 10,572 hours of training[59] - The company launched 4,284 self-directed courses on its E-learning platform, accumulating a total of 114,900 hours of learning[30] - The company aims for 100% coverage of grassroots management training by 2023 and 2024, enhancing the recognition of corporate culture among employees[30] Financial Performance - The company's operating revenue for the first half of 2023 was approximately ¥2.56 billion, representing a 17.71% increase compared to ¥2.17 billion in the same period last year[18] - Net profit attributable to shareholders was approximately ¥428.17 million, an increase of 18.62% from ¥360.95 million in the previous year[18] - The net profit after deducting non-recurring gains and losses was approximately ¥384.59 million, up 19.08% from ¥322.98 million year-on-year[18] - The net cash flow from operating activities increased by 53.57% to approximately ¥167.23 million, compared to ¥108.89 million in the same period last year[18] - Basic earnings per share rose to ¥0.2548, reflecting an 18.51% increase from ¥0.2150 in the previous year[18] Investments and Acquisitions - The company has increased investments in new technologies and industries, focusing on pharmaceuticals, new materials, semiconductor chips, rail transportation, and new energy vehicles[7] - The company completed the acquisition of LGC Nanjing, now known as "Xipai Technology," to enhance its reference material business and fill existing gaps[35] - The company announced a cash acquisition of 100% equity in Guangzhou Weikang Pharmaceutical Technology Co., Ltd. for RMB 29 million on January 16, 2023[96] - On April 21, 2023, the company approved the acquisition and capital increase of 80% equity in Guangdong Niuwai Quality Technology Service Co., Ltd. for a total cash consideration of RMB 11.6 million and an additional capital increase of RMB 12 million[96] - The company acquired 100% of Guangzhou Weikang Pharmaceutical Technology Co., enhancing its capabilities in drug CMC research and related services, successfully assisting a client in obtaining approval for a drug[37] Quality Control and Compliance - The company emphasizes the importance of maintaining credibility and brand integrity, implementing a comprehensive quality control system to ensure the accuracy of testing reports[3] - The company has established a dedicated department to monitor policy changes and manage potential risks associated with regulatory developments in the testing industry[5] - The company has implemented a vertical management system for quality, health, safety, and environment (QHSE) across its subsidiaries and operational sites[4] - The company has established a quality management system based on ISO/IEC 17025 and ISO/IEC 17020, ensuring the accuracy and reliability of testing services[29] - The company has established a committee to maintain the independence and impartiality of its certification services[59] Market Position and Strategy - The company is focused on enhancing its market position through continuous improvement in service quality and compliance with international standards[5] - The company aims to enhance its market position through sustainable development and ESG initiatives, responding to the latest trends and regulations in the field[26] - The company plans to enhance its core competitiveness by improving operational capabilities and focusing on differentiated development in the inspection and testing sector[28] - The company is actively pursuing internationalization, upgrading its Singapore subsidiary to a regional headquarters to accelerate business expansion in Southeast Asia[41] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[120] Environmental and Sustainability Initiatives - The company has a strong focus on green low-carbon and ESG services, providing carbon footprint certification and sustainability assessments, leveraging over ten years of experience in the field[26] - The company has successfully maintained compliance with various environmental protection laws and standards, including the Air Pollution Prevention and Control Law[74] - The company has implemented various energy-saving measures to reduce carbon emissions, including the installation of high-performance shading facilities and efficient lighting designs[80] - The company reported a total emission of 0.09969 tons of non-methane total hydrocarbons, which is within the limits set by local environmental standards[76] - The company has established a scholarship fund of CNY 10,000 for students in environmental protection majors at Suzhou Agricultural Vocational and Technical College[81] Employee Engagement and Management - The company has implemented a performance appraisal scheme and employee stock ownership plan to enhance team stability and attract talent[31] - The first employee stock ownership plan involved 56 employees holding a total of 3,670,000 shares, representing 0.22% of the company's total share capital[68] - The second employee stock ownership plan included 22 participants holding 1,424,500 shares, accounting for 0.08% of the company's total share capital[69] - The company’s employee stock ownership plan has not resulted in any financial impact or accounting changes during the reporting period[72] - The company’s management team remains stable, with no changes reported in the employee stock ownership plan management committee[72] Research and Development - The company’s R&D investment amounted to ¥209,570,492.15, reflecting a year-on-year growth of 4.30%[43] - The company upgraded its postdoctoral innovation practice base to a corporate postdoctoral workstation, recruiting 8 postdoctoral researchers focusing on fields such as biomedicine and chip testing[32] - The company has established a research institute focused on digital strategy and standard development, enhancing its core competitiveness in testing technology[31] - The company actively participates in the revision of international standards in various fields, demonstrating its leading R&D capabilities recognized by the market and government[32] - The company successfully completed the national key R&D project on integrated inspection and testing service platforms, addressing quality control and evaluation standards in emerging industries[32] Financial Management and Reporting - The company reported a total comprehensive income for the first half of 2023 was CNY 439,847,305.04, compared to CNY 361,608,656.52 in the same period of 2022, indicating a significant increase[121] - The company’s total assets at the end of the reporting period were 5,776,952,018.91 CNY[134] - The company’s total liabilities at the end of the reporting period were CNY 1,854,448,426.58[140] - The company’s owner contributions included CNY 9,030,000.00 in common stock during the reporting period[139] - The financial report for the first half of 2023 has not been audited[114]

2023 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：元 | | | 占用方与上 | 上市公司核 | 2023年期初 | 2023 半年度 | 2023 半年 | 2023 半年 | 2023 年半年 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性 | 资金占用方名称 | 市公司 | 算的会计科 | 占用资金余 | 占用累计发 | 度占用资 | 度偿还累 | 度期末占用 | 占用形成 | 占用性质 | | 资金占用 | | 的关联关系 | 目 | 额 | 生金额（不 | 金的利息 | 计发生金 | 资金余额 | 原因 | | | | | | | | 含利息） | （如有） | 额 | | | | | 控股股 | | | | | | | | | | | | 东、实际 | | | | | | | | | | | | 控制人及 | | | | | | | | | | | | 其附属企 | | | | | | | | | | | | 业 | | | | | | | | | | | | 小计 ...

证券代码：300012 证券简称：华测检测 公告编号：2023-057 华测检测认证集团股份有限公司 | 序号 | 银行名称 | 授信额度（亿元） | 授信期限 | | --- | --- | --- | --- | | 1 | 招商银行股份有限公司 | 3 | 一年 | | 2 | 广发银行股份有限公司 | 3 | 一年 | | 3 | 浦发银行股份有限公司 | 3 | 三年 | | 4 | 农业银行股份有限公司 | 2 | 一年 | | 5 | 汇丰银行（中国）有限公司 | 1.62 | 三年 | | 6 | 中国银行股份有限公司 | 1.5 | 一年 | | 7 | 华润银行股份有限公司 | 1 | 一年 | | 8 | 工商银行股份有限公司 | 1 | 一年 | | 9 | 交通银行股份有限公司 | 1 | 一年 | | 10 | 成都银行股份有限公司 | 0.02 | 一年 | | | 合计 | 17.14 | | 公司最终授信额度及期限将以实际审批为准，具体融资金额将视公司经营实 际需求确定。公司董事会授权管理层代表本公司办理上述授信事宜，并签署有关 银行授信合同及文件规定的所有登记、备案和资料提 ...

关于为子公司开具履约保函的公告 证券代码：300012 证券简称：华测检测 公告编号：2023-056 华测检测认证集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于2023年8月10日召 开第六届董事会第七次会议，审议通过了《关于为子公司开具履约保函的议案》， 现将有关事项公告如下： 一、开具履约保函的概述 公司全资子公司华测工程检测有限公司（以下简称"华测工程"）与广州安 茂铁路建设管理有限公司签署了《南大干线（钟三路至东新高速）工程（涉铁部 分）第三方检测服务合同》及《南大干线（钟三路至东新高速）工程（涉铁部分） 第三方检测服务合同-补充合同》，按照合同约定需提供履约保函。为了缓解华 测工程保函保证金占用资金的情况，提高流动资金的使用效率，公司为华测工程 向浦发银行申请开具保函，本次履约保函金额为 537,355.60 元，期限为银行开 立之日起一年。华测工程 2023 年 6 月 30 日的资产负债率为 53.41%%，无需提交 股东大会审议。 二、被担保人基本情况 5、注册资本：500 ...

华测检测认证集团股份有限公司独立董事 关于第六届董事会第七次会议相关事项的独立意见 我们认为：公司本次为全资子公司开具履约保函能够缓解子公司保函保证金 占用资金的情况，提高其流动资金的使用效率，有利于华测工程检测有限公司的 发展。本次担保的内容和决策程序符合《深圳证券交易所创业板股票上市规则》 等相关规定，不存在损害公司及股东、特别是中小股东利益的情形。 作为公司的独立董事，本着对公司及全体股东负责的态度,按照实事求是的 原则，基于独立判断的立场，在仔细审阅了本次董事会的相关材料后，经审慎分 析，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司重大 资产重组管理办法》《上市公司证券发行管理办法》《关于在上市公司建立独立 董事制度的指导意见》《深圳证券交易所创业板股票上市规则》等法律法规、规 范性文件及《公司章程》等有关规定，发表如下独立意见： 一、关于 2023 年上半年控股股东及其他关联方资金占用、公司对外担保情 况独立意见 1、报告期内，公司不存在控股股东及其他关联方占用公司资金的情况，也 不存在以前年度发生并累计至 2023 年 6 月 30 日的关联方违规占用资金情况。 2、截至 202 ...

证券代码：300012 证券简称：华测检测 公告编号：2023-054 华测检测认证集团股份有限公司 第六届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）第六届董事会第七次会 议于 2023 年 7 月 31 日发出会议通知，2023 年 8 月 10 日以通讯表决方式召开。本 次会议应参与董事 7 名，实际参与董事 7 名，分别为：万峰、申屠献忠、钱峰、 刘极地、程海晋、曾繁礼、刘志权。会议由董事长万峰主持，董事会会议的举行 和召开符合国家有关法律、法规及《公司章程》的规定。经充分讨论和审议，会 议形成决议如下： 特此公告！ 公司《2023 年半年度报告全文》及《2023 年半年度报告摘要》具体内容详见 在巨潮资讯网的相关公告。 华测检测认证集团股份有限公司 董 事 会 二、会议以 7 票同意、0 票反对、0 票弃权，审议通过《关于为子公司开具履约保 函的议案》 董事会认为，公司本次为华测工程检测有限公司开具履约保函是为了满足其 签订项目合同的需要，华测工程检测有限公司是公司全资子公 ...

一、会议以 3 票同意、0 票反对、0 票弃权，审议通过《2023 年半年度报告全文 及摘要》 监事会认为，公司董事会编制和审核的《2023 年半年度报告全文及其摘要》 的程序符合法律、行政法规、中国证监会和深交所的规定，报告的内容真实、准 确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大 遗漏。 第六届监事会第七次会议决议公告 证券代码：300012 证券简称：华测检测 公告编号：2023-055 公司《2023 年半年度报告全文及摘要》具体内容详见巨潮资讯网的相关公告。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司 二、会议以 3 票同意、0 票反对、0 票弃权，审议通过《关于为子公司开具履约保 函的议案》 华测检测认证集团股份有限公司（以下简称"公司"）第六届监事会第七次 会议于 2023 年 7 月 31 日发出会议通知，2023 年 8 月 10 日以通讯表决方式召开。 本次会议应参加监事 3 人，实际参加监事 3 人，分别为：陈炜明、杜学志、张渝 民。本次会议召开符合《公司法》和《公司章程》的有 ...

Financial Performance - The company's revenue for Q1 2023 was ¥1,117,097,334.31, representing a 23.07% increase compared to ¥907,659,635.64 in the same period last year[3] - Net profit attributable to shareholders was ¥144,260,702.30, up 20.37% from ¥119,849,299.00 year-on-year[3] - The company reported a basic earnings per share of ¥0.0862, an increase of 20.73% from ¥0.0714 in the same period last year[3] - The company's net profit for Q1 2023 reached CNY 148,109,863.17, an increase of 21.3% compared to CNY 122,149,340.74 in Q1 2022[18] - Operating profit for the quarter was CNY 169,159,598.51, up from CNY 134,711,029.74, reflecting a growth of 25.5% year-over-year[18] - The total comprehensive income attributable to the parent company was CNY 147,462,106.33, compared to CNY 119,844,122.99 in the previous year, reflecting a growth of 23.1%[19] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, with a net outflow of ¥24,179,495.64, a 75.30% reduction from a net outflow of ¥97,876,226.02 in the previous year[7] - The company reported a net cash outflow from operating activities of CNY -24,179,495.64, an improvement from CNY -97,876,226.02 in Q1 2022[21] - The cash and cash equivalents at the end of the period totaled CNY 1,386,964,555.65, compared to CNY 872,683,292.04 at the end of Q1 2022, indicating a significant increase of 58.8%[21] - The company's cash and cash equivalents at the end of Q1 2023 amount to ¥1,414,113,624.29, down from ¥1,601,569,785.65 at the beginning of the year[13] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥7,652,696,340.19, a decrease of 1.66% from ¥7,781,777,517.06 at the end of the previous year[3] - The company’s total liabilities increased, with long-term borrowings rising by 147.60% to ¥10,167,352.99 from ¥4,106,411.82 year-on-year[5] - The total liabilities decreased to ¥1,851,584,321.68, down 12.2% from ¥2,108,063,202.40[15] - The total number of common shareholders at the end of the reporting period is 34,141[9] - The largest shareholder, Hong Kong Central Clearing Limited, holds 14.37% with 241,810,162 shares[9] Operating Costs and Expenses - Total operating costs for Q1 2023 were ¥968,340,603.79, up 22.1% from ¥793,099,936.09 in the same period last year[17] - The company incurred financial expenses of CNY 247,139.55, a significant increase from CNY -717,585.78 in the previous year[18] - Research and development expenses increased to CNY 91,174,498.28, up from CNY 86,386,748.29, representing a rise of 5.5%[18] Shareholder Information - The company plans to release 25% of locked shares annually during the tenure of executives[11] - The total number of restricted shares at the beginning of the period was 159,184,188, with 3,697,500 shares released during the period[12] - The company has a total of 90,625,740 restricted shares held by Wan Feng, which remain locked during his tenure[11] - The company has a significant shareholder relationship, with Wan Yunxiang and Wan Feng being acting in concert[10] Other Financial Metrics - The company's non-current assets totaled ¥4,289,174,917.02, an increase of 10.1% from ¥3,894,342,672.30 at the end of the previous period[15] - The goodwill increased to ¥759,210,431.32, a significant rise of 23.9% from ¥613,319,550.86[15] - The company reported a decrease in accounts payable to ¥636,057,988.32, down 15.0% from ¥748,532,167.58[15] - Total current assets decreased to ¥3,363,521,423.17 from ¥3,887,434,844.76[13] - Accounts receivable decreased to ¥1,341,346,721.23 from ¥1,388,835,385.86[13] - Inventory increased to ¥109,137,412.93 from ¥97,332,127.76[13] Market Strategy - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided data[15] Audit Status - The first quarter report of Huace Testing Certification Group Co., Ltd. is unaudited[22]